Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    "Episodic ataxia"
Show Display Options
Rank Status Study
1 Enrolling by invitation 4-Aminopyridine in Episodic Ataxia Type 2
Condition: Episodic Ataxia Type 2
Interventions: Drug: 4-Aminopyridine;   Drug: Placebo
2 Unknown  Characteristics of Episodic Ataxia Syndrome
Conditions: Episodic Ataxia Syndrome;   Cerebellar Diseases
Intervention:
3 Active, not recruiting Biomarkers in Autosomal Dominant Cerebellar Ataxia
Conditions: Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia, Autosomal Recessive 3;   Episodic Ataxia, Type 7
Intervention: Other: metabolic and imaging biomarkers in SCA1,2,3 and 7 patients

Indicates status has not been verified in more than two years